Clinical Trial Update: Dexamethasone Implant for Retinal Detachment in Uveal Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a dexamethasone intravitreal implant for exudative retinal detachment associated with uveal melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exudative Retinal Detachment
• Uveal Melanoma

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant) (dexamethasone)

Snippet

Sponsor: Ivana K. Kim | Conditions: Exudative Retinal Detachment and Uveal Melanoma | Phase 1 | Status: COMPLETED